ArticlePregnancy (Hoboken, N.J.)2025
Maternal postpartum blood pressure screening at newborn visits and its impact on postpartum care utilization.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: To assess the impact of a maternal cardiovascular (CV) and blood pressure (BP) screening and standardized referral protocol at newborn visits on care utilization in the first 12 weeks postpartum. Methods: This prospective quality improvement initiative obtained maternal vital signs and CV symptoms at a pediatric academic practice. Elevated BP (≥140/90 mmHg) triggered enrollment into a remote BP management program, on-call Maternal-Fetal Medicine or Cardiology physician consultation, and/or emergency department (ED) referral. Unmatched control group were postpartum individuals of newborns seen on non-screening days in the same clinic. Outcomes included postpartum visit attendance, ED visits, readmissions, new postpartum hypertension (HTN) diagnosis, remote BP monitoring program enrollment, and postpartum antihypertensive initiation. Multivariable logistic regression was used to calculate odds ratios for postpartum care utilization outcomes and adjusted for demographic differences between groups (parity, BMI, gestational age, smoking) and other covariates related to postpartum care utilization (age, insurance, preexisting HTN). Interaction analyses tested effect modification by preexisting HTN status, with predictive margins calculated when significant using chi-square tests. Results: We included 132 screened individuals and 248 controls (77.9% non-White, 76.3% publicly insured). Among those screened, 34.1% ( Conclusion: This intervention detected more postpartum HTN while being associated with decreased odds of ED visits and readmissions. Acute care usage was similar for those with existing HTN, despite high rates of uncontrolled HTN at screening. This suggests maternal BP screening at newborn visits paired with remote BP monitoring may improve our postpartum patient outreach and be more feasible than traditional care while reducing acute care needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.